Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Schering Canada and University of Toronto collaborate on Alzheimer research

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Cortex claims AMPA receptor modulators for CNS disorders

Jan. 30, 1997

New steroidal anesthetics from Akzo Nobel

Jan. 30, 1997

Preliminary analysis of pivotal trials on transdermal buspirone announced

Jan. 29, 1997

New ropinirole formulation described by SKB

Jan. 29, 1997

HOP-1 claimed by Signal for treatment of CNS disorders

Jan. 29, 1997

NAChR agonist SIB-1765F: Potential antiparkinsonian agent

Jan. 28, 1997

Enantiospecific synthesis of SP antagonist from RPR

Jan. 28, 1997

Novartis selects analgesic agent as clinical candidate

Jan. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...